DK125097B - Analogifremgangsmåde til fremstilling af 5-substituerede 2-(5-nitro-2-furyl)-pyrimidiner eller deres salte med en fysiologisk tålelig syre eller saltene af tilsvarende kvaternære ammoniumforbindelser. - Google Patents

Analogifremgangsmåde til fremstilling af 5-substituerede 2-(5-nitro-2-furyl)-pyrimidiner eller deres salte med en fysiologisk tålelig syre eller saltene af tilsvarende kvaternære ammoniumforbindelser.

Info

Publication number
DK125097B
DK125097B DK364970AA DK364970A DK125097B DK 125097 B DK125097 B DK 125097B DK 364970A A DK364970A A DK 364970AA DK 364970 A DK364970 A DK 364970A DK 125097 B DK125097 B DK 125097B
Authority
DK
Denmark
Prior art keywords
salts
pyrimidines
furyl
nitro
substituted
Prior art date
Application number
DK364970AA
Other languages
Danish (da)
English (en)
Inventor
K Gutsche
R Albrecht
H Kessler
E Schroeder
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK125097B publication Critical patent/DK125097B/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Polyurethanes Or Polyureas (AREA)
  • Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
DK364970AA 1969-07-19 1970-07-14 Analogifremgangsmåde til fremstilling af 5-substituerede 2-(5-nitro-2-furyl)-pyrimidiner eller deres salte med en fysiologisk tålelig syre eller saltene af tilsvarende kvaternære ammoniumforbindelser. DK125097B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1937629A DE1937629C3 (de) 1969-07-19 1969-07-19 Nitrofuryl-aminoalkoxy-pyriinidine

Publications (1)

Publication Number Publication Date
DK125097B true DK125097B (da) 1972-12-27

Family

ID=5740764

Family Applications (1)

Application Number Title Priority Date Filing Date
DK364970AA DK125097B (da) 1969-07-19 1970-07-14 Analogifremgangsmåde til fremstilling af 5-substituerede 2-(5-nitro-2-furyl)-pyrimidiner eller deres salte med en fysiologisk tålelig syre eller saltene af tilsvarende kvaternære ammoniumforbindelser.

Country Status (19)

Country Link
US (1) US3707485A (de)
JP (1) JPS4911236B1 (de)
AT (1) AT294845B (de)
BE (1) BE753632A (de)
CA (1) CA929523A (de)
CH (1) CH540927A (de)
CS (1) CS166011B2 (de)
DE (1) DE1937629C3 (de)
DK (1) DK125097B (de)
ES (1) ES381433A1 (de)
FR (1) FR2059534B1 (de)
GB (1) GB1320548A (de)
IL (1) IL34882A (de)
NL (1) NL7010681A (de)
NO (1) NO127398B (de)
PL (1) PL70032B1 (de)
SE (1) SE367411B (de)
SU (1) SU471719A3 (de)
ZA (1) ZA704674B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2113529C3 (de) * 1971-03-17 1980-04-30 Schering Ag, 1000 Berlin Und 4619 Bergkamen 2-(5-Nitro-2-furyl)-5-(2-alkylaminoäthoxy)-pyrimidin-Verbindungen
JPS5131086U (de) * 1974-08-28 1976-03-06
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides
NZ527046A (en) 2001-01-16 2005-06-24 Vascular Therapies Llc A flexible cylindrical matrix material, preferably collagen with an antiproliferative agent preferably rapamycin dispersed throughout for implantation to be in contact with a vascular structure

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1695849A1 (de) * 1967-06-23 1971-05-13 Schering Ag Verfahren zur Herstellung neuer Pyrimidinderivate

Also Published As

Publication number Publication date
ZA704674B (en) 1971-03-31
FR2059534A1 (de) 1971-06-04
DE1937629B2 (de) 1978-11-16
NO127398B (de) 1973-06-18
IL34882A (en) 1972-10-29
AT294845B (de) 1971-12-10
US3707485A (en) 1972-12-26
BE753632A (fr) 1971-01-18
PL70032B1 (de) 1973-12-31
GB1320548A (en) 1973-06-13
SE367411B (de) 1974-05-27
CS166011B2 (de) 1976-01-29
FR2059534B1 (de) 1974-03-22
ES381433A1 (es) 1972-12-01
CA929523A (en) 1973-07-03
NL7010681A (de) 1971-01-21
SU471719A3 (ru) 1975-05-25
DE1937629A1 (de) 1971-02-11
JPS4911236B1 (de) 1974-03-15
CH540927A (de) 1973-08-31
DE1937629C3 (de) 1979-07-26

Similar Documents

Publication Publication Date Title
DK136651B (da) Analogifremgangsmåde til fremstilling af pyridinderivater, deres syreadditionssalte eller deres kvaternære ammoniumforbindelser.
DK124402B (da) Fremgangsmåde til fremstilling af heterocycliske benzamidoforbindelser eller kvaternære ammoniumsalte eller syreadditionssalte deraf.
DK111268B (da) Fremgangsmåde til fremstilling af 4-aryl-iso-flavan-derivater eller salter eller kvarternære ammoniumforbindelser deraf.
DK120341B (da) Analogifremgangsmåde til fremstilling af benzoxacinforbindelser eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK122133B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive substituerede 3-alkoxythianaphthen-2-carboxamider eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK136713B (da) Analogifremgangsmåde til fremstilling af alfa-aryl-4-substituerede piperidinoalkanolderivater eller deres syreadditionssalte.
DK129127B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(furylmethyl)-6,7-benzomorphaner eller deres syreadditionssalte.
DK119774B (da) Fremgangsmåde til fremstilling af antitussivt aktive 4-substituerede 2-benzhydryl-2-butanol-derivater eller syreadditionssalte deraf.
DK125097B (da) Analogifremgangsmåde til fremstilling af 5-substituerede 2-(5-nitro-2-furyl)-pyrimidiner eller deres salte med en fysiologisk tålelig syre eller saltene af tilsvarende kvaternære ammoniumforbindelser.
DK122326B (da) Analogifremgangsmåde til fremstilling af kvaternære 5-pyridinium-methyl-4-amino-pyrimidinsaltforbindelser eller syreadditionssalte deraf.
DK137758B (da) Analogifremgangsmåde til fremstilling af 2-(5-nitro-2-imidazolyl)-benzimidazoler eller salte deraf.
DK117902B (da) Fremangsmåde til fremstilling af 4-substituerede 2-(5-nitro-2-furyl)-kinazoliner eller syreadditionssalte deraf.
DK131030B (da) Fremgangsmåde til fremstilling af N-diethylaminoethyl-2-methoxy-4-amino-5-chlorbenzamid eller syreadditionssalte eller kvaternære ammoniumsalte heraf.
DK134434B (da) Analogifremgangsmåde til fremstilling af cis-A-decahydro-5-phenyl-4,1-benzoxazepiner eller syreadditionssalte, kvaternære ammoniumsalte eller N-oxider deraf.
DK129718B (da) Analogifremgangsmåde til fremstilling af tiazolino-pyrimidin-5-oner eller deres syreadditionssalte eller de tilsvarende optisk aktive forbindelser.
DK130114B (da) Analogifremgangsmåde til fremstilling af 5,6-dihydrofenantridinderivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK136242B (da) Analogifremgangsmåde til fremstilling af substituerede benzyloxyaminer eller deres syreadditionssalte.
DK107875C (da) Fremgangsmåde til fremstilling af heterocykliske sulfonylcarbaminsyrederivater eller syreadditionssalte deraf.
DK127501B (da) Analogifremgangsmåde til fremstilling af substituerede phenoxyethylaminer eller deres syreadditionssalte.
DK129195B (da) Analogifremgangsmåde til fremstilling af 11-aminoalkyl-dibenzo[a,d]-cycloheptatrien-derivater eller syreadditionssalte eller kvaternære ammoniumsalte deraf.
DK125889B (da) Analogifremgangsmåde til fremstilling af 1-alkyl-1-(beta;-piperidinoethyl)-1,2,3,4-tetrahydro-naphthalen-2-on-forbindelser eller deres syreadditionssalte.
DK122128B (da) Analogifremgangsmåde til fremstilling af racemiske eller optisk aktive 2-(4,4'-dihalo)-benzhydryl-3-quinuclidinoler eller syreadditionssalte deraf.
DK129033B (da) Analogifremgangsmåde til fremstilling af propiophenonforbindelser eller deres optisk aktive isomere eller diastereomere eller salte eller kvaternære ammoniumforbindelser deraf.
DK126650B (da) Analogifremgangsmåde til fremstilling af N-metyl-4-[o-fenætylbenzoyloxy]-piperidin eller syreadditionssalte eller kvaternære ammoniumforbindelser heraf.
DK136359B (da) Fremgangsmåde til fremstilling af heterocykliske benzamidforbindelser eller N-oxider, kvaternære ammonium- eller syreadditionssalte heraf.